Ma P - Search Results

1

Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation.

He Y, Ji Z, Gong Y, Fan L, Xu P, Chen X, Miao J, Zhang K, Zhang W, Ma P, Zhao H, Cheng C, Wang D, Wang J, Jing N, Liu K, Zhang P, Dong B, Zhuang G, Fu Y, Xue W, Gao WQ, Zhu HH. He Y, et al. Among authors: ma p. Cell Rep. 2023 Feb 28;42(2):112033. doi: 10.1016/j.celrep.2023.112033. Epub 2023 Jan 31. Cell Rep. 2023. PMID: 36724072 Free article.

2

Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit.

Zhang Z, Zhang S, Ma P, Jing Y, Peng H, Gao WQ, Zhuang G. Zhang Z, et al. Among authors: ma p. Carcinogenesis. 2015 Sep;36(9):937-45. doi: 10.1093/carcin/bgv085. Epub 2015 Jun 12. Carcinogenesis. 2015. PMID: 26071398

3

Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.

Zhang S, Jing Y, Zhang M, Zhang Z, Ma P, Peng H, Shi K, Gao WQ, Zhuang G. Zhang S, et al. Among authors: ma p. Sci Rep. 2015 Nov 4;5:16066. doi: 10.1038/srep16066. Sci Rep. 2015. PMID: 26530441 Free PMC article.

4

Concomitant BET and MAPK blockade for effective treatment of ovarian cancer.

Jing Y, Zhang Z, Ma P, An S, Shen Y, Zhu L, Zhuang G. Jing Y, et al. Among authors: ma p. Oncotarget. 2016 Jan 19;7(3):2545-54. doi: 10.18632/oncotarget.6309. Oncotarget. 2016. PMID: 26575423 Free PMC article.

5

BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.

Zhang Z, Ma P, Jing Y, Yan Y, Cai MC, Zhang M, Zhang S, Peng H, Ji ZL, Di W, Gu Z, Gao WQ, Zhuang G. Zhang Z, et al. Among authors: ma p. Theranostics. 2016 Jan 1;6(2):219-30. doi: 10.7150/thno.13178. eCollection 2016. Theranostics. 2016. PMID: 26877780 Free PMC article.

6

Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK Pathway.

Ma P, Fu Y, Chen M, Jing Y, Wu J, Li K, Shen Y, Gao JX, Wang M, Zhao X, Zhuang G. Ma P, et al. Theranostics. 2016 May 24;6(8):1232-43. doi: 10.7150/thno.14409. eCollection 2016. Theranostics. 2016. PMID: 27279914 Free PMC article.

7

Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer.

Zhang Z, Peng H, Wang X, Yin X, Ma P, Jing Y, Cai MC, Liu J, Zhang M, Zhang S, Shi K, Gao WQ, Di W, Zhuang G. Zhang Z, et al. Among authors: ma p. Mol Cancer Ther. 2017 Sep;16(9):1739-1750. doi: 10.1158/1535-7163.MCT-17-0078. Epub 2017 Jun 1. Mol Cancer Ther. 2017. PMID: 28572168

8

Clonality, Heterogeneity, and Evolution of Synchronous Bilateral Ovarian Cancer.

Yin X, Jing Y, Cai MC, Ma P, Zhang Y, Xu C, Zhang M, Di W, Zhuang G. Yin X, et al. Among authors: ma p. Cancer Res. 2017 Dec 1;77(23):6551-6561. doi: 10.1158/0008-5472.CAN-17-1461. Epub 2017 Sep 28. Cancer Res. 2017. PMID: 28972072

9

Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer.

Ma P, Fu Y, Cai MC, Yan Y, Jing Y, Zhang S, Chen M, Wu J, Shen Y, Zhu L, Chen HZ, Gao WQ, Wang M, Gu Z, Bivona TG, Zhao X, Zhuang G. Ma P, et al. Nat Commun. 2017 Oct 10;8(1):823. doi: 10.1038/s41467-017-00963-0. Nat Commun. 2017. PMID: 29018192 Free PMC article.

10

Prevalence and clonality of synchronous primary carcinomas in the bladder and prostate.

Jing Y, Zhang R, Ma P, Cai MC, Zhuang G, Chen H. Jing Y, et al. Among authors: ma p. J Pathol. 2018 Jan;244(1):5-10. doi: 10.1002/path.4997. J Pathol. 2018. PMID: 29023722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,265 results

Search Page